{"id":"NCT03932240","sponsor":"Emory University","briefTitle":"In Vivo Effects of Fibrinogen Concentrate (FC) Versus Cryoprecipitate on the Neonatal Fibrin Network Structure After Cardiopulmonary Bypass (CPB)","officialTitle":"In Vivo Effects of Fibrinogen Concentrate (FC) Versus Cryoprecipitate on the Neonatal Fibrin Network Structure After Cardiopulmonary Bypass (CPB)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-08-13","primaryCompletion":"2021-04-09","completion":"2021-11-16","firstPosted":"2019-04-30","resultsPosted":"2023-03-20","lastUpdate":"2024-02-20"},"enrollment":36,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Hemostasis"],"interventions":[{"type":"DRUG","name":"Fibrinogen Concentrate (FC)","otherNames":["RiaSTAP"]},{"type":"DRUG","name":"Cryoprecipitate","otherNames":[]}],"arms":[{"label":"Fibrinogen Concentrate (FC)","type":"EXPERIMENTAL"},{"label":"Cryoprecipitate","type":"ACTIVE_COMPARATOR"}],"summary":"This primary aim of this study is to compare the in vivo effects of fibrinogen concentrate and cryoprecipitate on the neonatal fibrin network after surgery with cardiopulmonary bypass to develop effective and safe strategies for managing coagulopathies in neonates.","primaryOutcome":{"measure":"Clot Degradation at 24 Hours Post-operatively","timeFrame":"From induction of anesthesia to 24 hours postoperatively","effectByArm":[{"arm":"Fibrinogen Concentrate (FC)","deltaMin":0.65,"sd":null},{"arm":"Cryoprecipitate","deltaMin":0.88,"sd":null}],"pValues":[]},"eligibility":{"minAge":"1 Day","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["39116012"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":18},"commonTop":["Arrhythmia","Thrombosis"]}}